EA201300377A1 - ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) - Google Patents

ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Info

Publication number
EA201300377A1
EA201300377A1 EA201300377A EA201300377A EA201300377A1 EA 201300377 A1 EA201300377 A1 EA 201300377A1 EA 201300377 A EA201300377 A EA 201300377A EA 201300377 A EA201300377 A EA 201300377A EA 201300377 A1 EA201300377 A1 EA 201300377A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
options
therapeutic effect
antioxidant
antioxidant pharmaceutical
Prior art date
Application number
EA201300377A
Other languages
Russian (ru)
Inventor
Анастасия Геннадьевна ЧЕЛЯЕВА
Владимир Павлович ЛОБКО
Original Assignee
Ооо "Фармацевтическая Компания "Славянская Аптека"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ооо "Фармацевтическая Компания "Славянская Аптека" filed Critical Ооо "Фармацевтическая Компания "Славянская Аптека"
Priority to EA201300377A priority Critical patent/EA201300377A1/en
Publication of EA201300377A1 publication Critical patent/EA201300377A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Изобретение относится к области фармацевтической промышленности, медицине. Задачей настоящего изобретения является создание эффективного антиоксидантного фармацевтического состава. Задача решается за счет того, что антиоксидантный фармацевтический состав, содержащий метилэтилпиридинола гидрохлорид, дополнительно содержит минеральные вещества натрий, калий, кальций, магний, железо, марганец, а также содержит изотопы углеродаС и изотопы азотаN. Изобретение описано в четырех вариантах реализации. Техническими результатами изобретения являются увеличение срока годности фармацевтического состава; увеличение лечебного эффекта, а также скорости наступления лечебного эффекта.The invention relates to the field of pharmaceutical industry, medicine. The present invention is the creation of an effective antioxidant pharmaceutical composition. The problem is solved due to the fact that the antioxidant pharmaceutical composition containing methylethylpyridinol hydrochloride additionally contains minerals sodium, potassium, calcium, magnesium, iron, manganese, and also contains carbon isotopes and nitrogen isotopesN. The invention is described in four embodiments. The technical results of the invention are to increase the shelf life of the pharmaceutical composition; increase therapeutic effect, as well as the rate of onset of therapeutic effect.

EA201300377A 2013-04-19 2013-04-19 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS) EA201300377A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201300377A EA201300377A1 (en) 2013-04-19 2013-04-19 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201300377A EA201300377A1 (en) 2013-04-19 2013-04-19 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Publications (1)

Publication Number Publication Date
EA201300377A1 true EA201300377A1 (en) 2014-10-30

Family

ID=51794631

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300377A EA201300377A1 (en) 2013-04-19 2013-04-19 ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)

Country Status (1)

Country Link
EA (1) EA201300377A1 (en)

Similar Documents

Publication Publication Date Title
JO3438B1 (en) Aryl- or heteroaryl-substituted benzene compounds
EA201591591A1 (en) COMPOUNDS OF CARBAZOLE APPLIED AS Bromodomain Inhibitors
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
EA201690561A1 (en) Peptidylnitrile compounds as inhibitors of dipopeptidyl peptidase I
EA201300377A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300392A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300393A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300394A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300376A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300372A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300378A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300371A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300373A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201300370A1 (en) ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
EA201200359A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200343A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200858A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)
EA201200338A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200360A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200314A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200345A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200339A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201200337A1 (en) PHARMACEUTICAL COMPOSITION, HAVING A NEUROPROTECTIVE, ANTI-AMNESTIC, ANTIOXIDANT, ANTIPIOPOXIC, NEUROMETABOLIC, ANTIVYCHEMICAL ACTIVITY (OPTIONS)
EA201201217A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)
EA201201220A1 (en) PHARMACEUTICAL COMPOSITION, HAVING METABOLIC, ANTI-PATH, RETINOPROTECTIVE ACTION (OPTIONS)